Alpha Tau Medical
DRTS
27 hedge funds and large institutions have $5.35M invested in Alpha Tau Medical in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
4% more funds holding
Funds holding: 26 → 27 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.47% less ownership
Funds ownership: 3.09% → 2.62% (-0.47%)
17% less capital invested
Capital invested by funds: $6.42M → $5.35M (-$1.07M)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
+$91.3K |
| 2 |
ACA
Aptus Capital Advisors
Fairhope,
Alabama
|
+$36.7K |
| 3 |
UWM
USAdvisors Wealth Management
Eden Prairie,
Minnesota
|
+$31.4K |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$26.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$114 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$927K |
| 2 |
LA
LM Advisors
San Diego,
California
|
-$41.5K |
| 3 |
Renaissance Technologies
New York
|
-$30.4K |
| 4 |
SAM
Satovsky Asset Management
New York
|
-$30.2K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$30.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| $109 | +$114 | +37 | New |
|
27
Qube Research & Technologies (QRT)
London,
United Kingdom
| $71 | – | – | – |
|
|
LA
28
LM Advisors
San Diego,
California
| – | -$41.5K | -13,799 | Closed |
|
|
ASN
29
Advisory Services Network
Atlanta,
Georgia
| – | -$30.1K | -10,000 | Closed |
|
DRTS Hedge Fund Activity: Q1 2024 in Review
27 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q1 2024, worth a combined $5.35M — down 17% from $6.42M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DRTS positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Kovitz Investment Group Partners, opening a new position worth an estimated $91.3K. The largest seller was Morgan Stanley, cutting an estimated $927K.
- 27 institutional investors held Alpha Tau Medical (DRTS) as of Q1 2024, up from 26 in Q4 2023.
- Funds reported $5.35M of Alpha Tau Medical stock for Q1 2024, down 17% quarter-over-quarter.
- 4 funds opened new Alpha Tau Medical positions in Q1 2024 and 2 closed out, a net change of +2 holders.
- The largest Alpha Tau Medical buyer in Q1 2024 was Kovitz Investment Group Partners, an estimated $91.3K added.
- The largest Alpha Tau Medical seller in Q1 2024 was Morgan Stanley, an estimated $927K sold.
Based on aggregated 13F filings for Q1 2024.